High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma

Our objective is to identify genes regulating metastasis of osteogenic sarcoma (OGS) since metastasis is the primary cause of mortality among patients with OGS. To identify such genes, we first created a database of differentially expressed genes between six low-grade and six high-grade OGS tumors, and between a normal immortalized osteoblast cell line (FOB) and four commercially available OGS-derived cell lines. We specifically searched for surface proteins over-expressed in high-grade OGS, since we hypothesize that tumor-cell specific surface markers are key to metastasis. A gene encoding Tumor Endothelial Marker7 (TEM7) was selected as a candidate for further study. TEM7 expression pattern was assessed by RT-PCR, Western blotting and immunostaining. TEM7 mRNA was abundantly expressed in SAOS cells (derived from high-grade OGS), but not in FOB or MG63 cells (derived from low-grade OGS). Virtually no expression of TEM7 protein was observed in FOB cells but abundant expression was noted in SAOS and TE85 cells. Employing immunostaining of 92 human OGS specimens (50 high-grade and 42 low-grade) collected before chemotherapy show 97% (37 of 38) of high-grade OGS specimens with metastasis have high TEM7 staining. Further, we found that elevated expression of TEM7 correlated with poor survival (p<0.04) of affected patients. Inhibiting TEM7 function by siRNA inhibited invasion and migration of OGS cells with metastatic potential. Our results suggest TEM7 expression level closely parallels histology-based prognostication of OGS metastasis and, therefore, it is a therapeutic target. This is the first demonstration of a link between TEM7 and cancer metastasis.     

Miscibility studies of HPMC/PVA blends in water by viscosity, density, refractive index and ultrasonic velocity method

Hydroxy propyl methyl cellulose (HPMC)/polyvinyl alcohol (PVA) blends are edible polymer films used for food packing and directly in foodstuffs. However they are water-soluble in ordinary temperature and have good mechanical properties. The miscibility of HPMC/PVA blend in water was studied by viscosity, ultrasonic velocity, density and refractive index techniques at 30 and 50 °C. Using viscosity data, the interaction parameters μ and α were calculated. These values revealed that HPMC/PVA blend is miscible when the HPMC content is more than 60% in the blend at 30 and 50 °C. And also the result revealed that the change in temperature has no significant effect on the miscibility of HPMC/PVA polymer blend.     

Miscibility studies of HPMC/PEG blends in water by viscosity,density, refractive index and ultrasonic velocity method

Hydroxy propyl methyl cellulose (HPMC)/polyethylene glycol (PEG) blends are edible polymer films used for food packing and directly in foodstuffs. However, they are water-soluble in ordinary temperature and have good mechanical properties. The miscibility of HPMC/PEG blend in water was studied by viscosity, ultrasonic velocity, density and refractive index techniques at 30 and 50 °C. Using viscosity data, the interaction parameters μ and α were calculated. These values revealed that HPMC/PEG blend is miscible when the HPMC content is more than 60 wt.% in the blend at 30 and 50 °C, below which is immiscible. Further the result was also confirmed by ultrasonic velocity, density, refractive index measurements, which also revealed that the change in temperature has no significant effect on the miscibility of HPMC/PEG polymer blend.     

Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase

A series of inhibitors of mammalian 15-lipoxygenase based on tryptamine and homotryptamine scaffolds is described. Compounds with aryl substituents at C-2 of the indole core of tryptamine and homotryptamine sulfonamides (e.g., 37a-p) proved to be potent inhibitors of the isolated enzyme. Selected compounds also demonstrated desirable inhibition selectivities over isozymes 5- and P-12-LO.     

Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells

Noncovalent protein delivery into cells via peptide carriers is an emerging concept. Only a handful of such peptides are known. To address various limitations associated with protein delivery for therapeutic purposes, a greater number of different delivery peptides would be required. No general method exists for creating such peptides. By combining a sequence of 16 lysine residues (K16) with the signal peptide (SP) sequence of Kaposi's fibroblast growth factor (K-FGF), we have synthesized a peptide (K16SP) that efficiently and noncovalently delivers functionally intact proteins (immunoglobulin G molecules, beta-galactosidase, and green fluorescent protein) into mammalian cells. The peptides K16 and SP each alone did not show any noncovalent protein-carrying capacity. K16SP appears to be nontoxic to cells and three to four times more efficient than a commercially available peptide reagent. Our approach offers proof-of-concept of a general strategy for creating a diverse array of peptide carriers for eventual therapeutic applications.     

Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists

A series of 4'-[(imidazol-1-yl)methyl]biphenylsulfonamides has potent antagonist activity against both angiotensin II AT(1) and endothelin ET(A) receptors. Such dual-acting antagonists could have utility in the treatment of hypertension, heart failure, and other cardiovascular diseases in a broad patient population. Certain compounds in the present series are orally active in a rat model of angiotensin II-mediated hypertension.